卢敏辨治绝经后骨质疏松临床撷菁
LU Min's Clinical Treatment of Postmenopausal Osteoporosis
DOI:10.13192/j.issn.1000-1719.2019.11.012
扫 描 看 全 文
1.湖南中医药大学,湖南 长沙 410208
2.湖南中医药大学第一附属医院,湖南 长沙 410007
扫 描 看 全 文
段航, 卢敏, 蒋梁, 等. 卢敏辨治绝经后骨质疏松临床撷菁[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.11.012
DUAN Hang, LU Min, JIANG Liang, et al. LU Min's Clinical Treatment of Postmenopausal Osteoporosis[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.11.012
段航, 卢敏, 蒋梁, 等. 卢敏辨治绝经后骨质疏松临床撷菁[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.11.012 DOI:
DUAN Hang, LU Min, JIANG Liang, et al. LU Min's Clinical Treatment of Postmenopausal Osteoporosis[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2019.11.012 DOI:
文章将卢敏教授治疗绝经后骨质疏松的有效案例进行统计,探讨卢敏教授辨治绝经后骨质疏松的临床经验。卢敏教授认为绝经后骨质疏松主要病机为“虚”“瘀”,虚责之于气血亏虚、肝肾亏虚,瘀责之于气滞血瘀、气虚血瘀,临证之时应结合脏腑、气血辨证。在治疗上,卢敏教授灵活使用经验方,病证结合,处方具有祛邪不伤正,脾肾同调,气血并治,筋骨并重的特点,结合中医外治疗法,重视宣教及功能锻炼,临床取得较好的效果。
This article summarized Professor LU Min's effective cases of postmenopausal osteoporosis and explore the clinical experience of Professor LU Min in the treatment of postmenopausal osteoporosis. Professor LU Min believes that the main pathogenesis of postmenopausal osteoporosis is deficiency and phlegm. The deficiency is due to Qi and blood deficiency, liver and kidney deficiency, and the phlegm due to Qi stagnation and blood stasis, Qi deficiency and blood stasis. At that time, it should be combined with Zang-fu organs and Qi and blood to make the syndrome differentiation. In the treatment, Professor LU Min flexibly uses the experience formula, combining the disease and syndromes. The prescription has the characteristics of treating spleen and kidney simultaneously, regulating Qi and blood, paying attention to the bones and bones and attaching importance to education and functional exercise. It has achieved clinically good results.
绝经后骨质疏松名老中医经验卢敏
postmenopausal osteoporosisold Chinese medicine experienceLU Min
Burge R, Dawson-Hughes B, Solomon DH, et al. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025[J]. J Bone Miner Res, 2007 (22): 465-475.
Whitaker M, Guo J, Kehoe T, Benson G. Bisphosphonates for osteoporosis--where do we go from here?[J]. N Engl J Med, 2012, 366(22): 2048-2051.
Yilmaz , MIsaoglu U, Uslu T, et al. Effect of methylprednisoloneon bone mineral density in rats with ovariectomy-induced bone loss and suppressed endogenous adrenaline levels by metyrosine[J]. Indian J Pharmacol, 2013, 45(4): 344-347.
de Villiers TJ, Hall JE, Pinkerton JV, et al. Revised Global Consensus Statement on Menopausal Hormone Therapy[J]. Climacteric, 2016, 19: 313-315.
Baber RJ, Panay N, Fenton A. 2016 IMS Recommendationson women's midlife health and menopause hormone therapy[J]. Climacteric, 2016, 19: 109-150.
王冰, 编. 黄帝内经素问[M]. 南宁: 广西科学技术出版社, 2016: 12.
佚名,著. 黄帝内经灵枢[M]. 北京: 中国医药科技出版社, 2018: 1.
王清任. 中医临床实用经典丛书医林改错大字版[M]. 北京: 中国医药科技出版社, 2018.
薛己著. 正体类要[M]. 上海: 上海科学技术出版社, 1959: 4.
施杞, 石仰山. 石筱山伤科学[M]. 北京: 人民卫生出版社, 2014.
刘心萍, 陈方亮, 程亚军. 黄芪总黄酮防止大鼠骨质疏松的实验研究[J]. 浙江中西医结合杂志, 2005, 15(15): 282-283.
李芳芳, 宋士军, 李建平, 等. 淫羊藿对成骨细胞增殖分化的影响[J]. 中国骨质疏松杂志, 1999, 5(2): 70.
樊粤光, 黄永明, 曾意荣, 等. 骨碎补提取液对体外分离破骨细胞性骨吸收的作用[J]. 中国中医骨伤科杂志, 2003, 11(6): 4.
王猛, 张新, 孙艳涛. 浅谈牛膝的化学成分与功效关系[J]. 山东医药工业, 2003, 22(2): 44.
陈晓超, 柯李晶, 陈躬瑞, 等. 鹿茸粗提液对大鼠成骨肉瘤细胞增殖的调节作用[J]. 中国中药杂志, 2004, 29(1): 74.
刘永新,编著. 图解本草纲目[M]. 北京: 中医古籍出版社, 2018.
孟洗著. [M]. 北京: 人民卫生出版社, 1984: 7.
莫枚士. 神农本经校注[M]. 北京: 中国中医药出版社, 2015: 12.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构